Immunological detection of RNA:DNA hybrids on microarrays
AssigneeDigene Corporation
InventorsJames G. Lazar, Joan M. Zakel, Christina M. Strange, Inna R. Williams, Attila T. Lorincz, Abel De La Rosa
Life of this patent
Estimating the term…
Loading patent…
AssigneeDigene Corporation
InventorsJames G. Lazar, Joan M. Zakel, Christina M. Strange, Inna R. Williams, Attila T. Lorincz, Abel De La Rosa
Estimating the term…
The present invention provides a hybridization method and kit for the detection and measurement of biological molecules. A test sample containing the biological molecules of interest is hybridized with an unlabeled or optionally a detectably labeled complementary biomolecule to form a double-stranded hybrid immobilized to a solid phase. The immobilized hybrid may be detected with an entity which specifically recognizes an RNA:DNA hybrid, followed by analyses and quantification. Therefore, the present invention provides a method and kit to detect and measure biological molecules that is simple to use, highly specific, sensitive, and accurate for screening a plurality of biological molecules.
A method for detecting or quantifying a target nucleic acid on a solid support having a plurality of sample detection sites, comprising:
A method for detecting or quantifying a target nucleic acid on a solid support having a plurality of sample detection sites, comprising:
A method for detecting or quantifying a target nucleic acid on a solid support having a plurality of sample detection sites, comprising:
A method for detecting or quantifying a target nucleic acid on a solid support having a plurality of sample detection sites, comprising:
Dependencies are inferred from the claim text.